Brain abscess
ICD-10 G06.0 · ICD-11 1D03.3

Community-Acquired Brain Abscess Not Responding to Initial Treatment

When initial neurosurgical and antibiotic management of community-acquired brain abscess does not produce the expected clinical and radiological response, a defined next-line protocol specifies the appropriate escalation.

Prior treatment not achieving goals

What triggers escalation to this protocol?

The first-line approach for community-acquired brain abscess combines neurosurgical aspiration or excision with empirical intravenous antibiotics — including a 3rd-generation cephalosporin and metronidazole. Two benchmarks determine whether that treatment is working:

When either benchmark is not met, this next-line protocol applies.

What the next-line protocol involves

The next step centres on further neurosurgical intervention. The choice of approach depends on clinical and imaging findings at the time of reassessment. The complete structured regimen — including indications, decision criteria, and supporting measures — is available via the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.cmi.2023.08.016

We strongly recommend 3rd-generation cephalosporin combined with metronidazole for empirical treatment of community-acquired brain abscess in children and adults (Table 4) (strong recommendation and low certainty of evidence).

Repeated neurosurgical aspiration, or in selected cases excision, should be carried out in case of clinical deterioration or enlargement of brain abscess, and is almost always required in those without any reduction in brain abscess volume by 4 weeks after first aspiration (good clinical practice statement).

View source ↗